| Net Cash Provided by (Used in) Operating Activities |
$45,220 |
USD |
-49% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$42,000 |
USD |
-16% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
441,480,473 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$3,220 |
USD |
-116% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$20,530 |
USD |
-28% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$369,000 |
USD |
-72% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$369,000 |
USD |
-72% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$369,000 |
USD |
16% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
3,000,000 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
$86,727 |
USD |
12% |
Q1 2025 |
Q1 2025 |